HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
75.40
-0.90 (-1.18%)
Apr 24, 2025, 1:43 PM CST

HeXun Biosciences Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
200.99257.67119.7485.03
Short-Term Investments
1727272-
Cash & Short-Term Investments
372.99329.67191.7485.03
Cash Growth
13.14%71.94%125.51%-
Receivables
84.6822.284.98-
Inventory
15.584.6--
Prepaid Expenses
8.336.859.448.37
Other Current Assets
1.670.275.080.01
Total Current Assets
483.25363.67211.2493.4
Property, Plant & Equipment
139.1113.9394.27102.83
Other Intangible Assets
26.6734.2641.231.75
Long-Term Deferred Tax Assets
1.57---
Other Long-Term Assets
56.3459.5757.4196.64
Total Assets
706.92571.43404.15294.62
Accounts Payable
4.242.433.232.81
Accrued Expenses
19.169.653.211.42
Current Portion of Long-Term Debt
-2.552.350.59
Current Portion of Leases
3.042.842.132.07
Current Income Taxes Payable
15.65---
Current Unearned Revenue
8.71.733.6-
Other Current Liabilities
2.9710.985.510.93
Total Current Liabilities
53.7630.1720.037.83
Long-Term Debt
-34.937.2639.41
Long-Term Leases
31.9832.3229.932.03
Long-Term Unearned Revenue
--1.5-
Other Long-Term Liabilities
0.60.60.60.6
Total Liabilities
86.3498.0789.2879.87
Common Stock
460460410360
Additional Paid-In Capital
130.3130.355.3-
Retained Earnings
30.28-116.95-150.44-145.25
Shareholders' Equity
620.58473.36314.87214.75
Total Liabilities & Equity
706.92571.43404.15294.62
Total Debt
35.0272.6171.6474.1
Net Cash (Debt)
337.97257.06120.1110.93
Net Cash Growth
31.47%114.03%999.17%-
Net Cash Per Share
7.345.673.200.36
Filing Date Shares Outstanding
46464630.51
Total Common Shares Outstanding
46464130.51
Working Capital
429.49333.5191.2285.58
Book Value Per Share
13.4910.297.687.04
Tangible Book Value
593.91439.09273.64213.01
Tangible Book Value Per Share
12.919.556.676.98
Machinery
118.9582.4963.5763.23
Leasehold Improvements
29.822821.6920.92
Source: S&P Global Market Intelligence. Standard template. Financial Sources.